Around one-third of patients with peripheral arterial disease (PAD) fail to receive appropriate antiplatelet treatment, warns a review from an expert panel, which highlights the huge cost of sub-optimal treatment of PAD on the NHS, the economy as a whole and on the individuals affected.
Cardiovascular risk management series: 2 – Using guidelines as a framework for cardiovascular risk management
Reducing the impact of vascular disease: the proposed Vascular Risk Programme for risk assessment and management
Measurement of baseline total cholesterol: new data from The Health Improvement Network (THIN) database
Ambulatory ECG monitoring in primary care
Cardiac arrhythmia affects more than 700,000 people in England and is consistently in the top ten reasons for hospital admission, consuming significant accident and emergency time and bed days.1 In the general population, arrhythmias are normally quite minor, silent, and typically benign. Symptoms may affect the patient enough to be both disruptive and distressful. In […]
